Roth Capital Starts Recro Pharma (REPH) at Buy

September 16, 2016 8:45 AM EDT
Get Alerts REPH Hot Sheet
Price: $7.15 --0%

Rating Summary:
    4 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade REPH Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Roth Capital initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $24.00.

For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.

Shares of Recro Pharma closed at $9.31 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment